Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Elliott lifts Toyota Industries stake in bid to block management buyout
Elliott lifts Toyota Industries stake in bid to block management buyout Elliott Management has raised its stake in Toyota Industries to about 7.1%, intensifying its campaign against a proposed management-led buyout of the Japanese manufacturer, according to Bloomberg....
Goldman leans on bonds in $3.75bn debt package for DuPont aramids carve-out
Goldman leans on bonds in $3.75bn debt package for DuPont aramids carve-out Goldman Sachs is preparing a $3.75bn financing package to support Arclin’s acquisition of DuPont’s aramids business, highlighting shifting dynamics in leveraged finance markets, according to...
La Caisse launches $1.5bn China-focused PE secondary sale as pensions rebalance exposure
La Caisse launches $1.5bn China-focused PE secondary sale as pensions rebalance exposure La Caisse de dépôt et placement du Québec is seeking to sell about $1.5bn of China-focused private equity fund stakes, says Bloomberg. People familiar with the matter said the...